The Business Group on Health Annual Conference draws the kind of audience that does not need to be sold on the complexity of employer health benefits. CFOs, benefits leaders, and pharmacy directors arrive already carrying the weight of rising costs, chronic condition management, and the pressure to extract more value from constrained budgets. The 2026 edition, held this week in New Orleans, made clear that those pressures are not easing.
A few themes ran through the sessions with enough consistency to be worth naming.
- The gap between what’s covered and what’s working.
Employers have spent years building benefit programs designed to drive better outcomes. The harder conversation now is why those programs are not performing as expected. Prescription abandonment, therapy non-initiation, and early drop-off are not fringe issues. These showed up repeatedly in how employers framed their frustrations this week.
- Vendor accountability has moved from aspiration to requirement.
Employers are no longer satisfied with measuring engagement or tracking utilization. They want to know whether their pharmacy and health programs are demonstrably reducing spend and improving care. The shift from outputs to outcomes is real, and organizations that cannot produce verified results are losing credibility with finance and benefits leadership alike.
- Complexity is a cost driver.
Session after session returned to a version of the same problem: the more complicated a program is, the less it delivers. Employees disengage. Physicians push back. Administrators spend time managing confusion instead of managing care. The employers generating the most traction are the ones simplifying their approach, not layering more onto it.
- AI and technology are tools, not answers.
Interest in AI-enabled health and pharmacy solutions was high, but so was skepticism. Employers want technology that solves a defined problem without creating new operational burden. The appetite is for invisible infrastructure with visible results, not platforms that require implementation teams and behavior change campaigns to function.
The underlying connector between these themes is layers of misaligned incentives. Employers are funding benefits, absorbing cost, and measuring outcomes, while the activation burden for almost every program sits somewhere else. The vendor has to enroll members. Enrolled members have to initiate the savings opportunity. The physician still doesn’t have visibility into their patient’s drug cost. And when any of those links break, the employer pays for the mismatch.
The conversations in New Orleans this week made one thing clear: employers are not looking for another program that depends on someone else to act first. They are ready for a model that puts the right clinical decision in front of the right person at the right moment, with the employer’s cost reality already built in. That appetite was real this week and RazorMetrics was there ready to deliver.
RazorMetrics is proud to be a sponsor at this year’s Business Group on Health Conference. The Business Group on Health is a network of professionals helping large employers optimize business performance by improving the way they approach health and benefits. They leverage a network of members to share best practices, shape health care policy and craft innovative solutions for the health care issues employers care about.
